Does low IgM predict varicella-zoster reactivation risk?

At age 83, herpes-zoster susceptibility is more directly shaped by waning VZV-specific cellular immune surveillance than by a low total IgM concentration. The claim is therefore well aligned with current immunology.

Clinical and immunologic evidence

• VZV remains latent in sensory ganglia, where VZV-specific CD4+ and CD8+ T-cell responses suppress reactivation and limit replication. Age-related immunosenescence reduces this virus-specific cell-mediated immunity and helps explain the substantially greater zoster risk in older adults.
• Immunosuppressive diseases and therapies can further impair this protective pathway. By contrast, circulating VZV antibody often persists with age and does not reliably predict zoster incidence, severity, or pain.
• Low total IgM is biologically consistent with reduced early humoral capacity: pentameric IgM has high functional avidity and efficiently activates classical complement, promoting C3 deposition, opsonization, and phagocytic clearance. Yet serum total IgM does not measure pathogen-specific IgM, avidity, complement function, or compensatory IgG/IgA responses.

Interpretation and practical implications

• Low IgM should be treated as a contextual immune finding rather than evidence that it caused an individual VZV reactivation. Reports of zoster in selective IgM deficiency are sparse—one affected person in a 62-adult cohort and isolated case reports—and do not establish independent risk or causality.
• If clinically relevant, repeat IgM together with IgG and IgA when well; interpret persistence alongside infection history, medications, secondary causes, protein loss, malignancy, and selected functional antibody or lymphocyte testing.
• Recombinant zoster vaccine provides a biologically targeted preventive strategy, inducing robust glycoprotein-E–specific Th1 CD4+ effector and memory responses in adults aged ≥70 years and demonstrating high protection against herpes zoster.

Bottom line

• Low total IgM may signal reduced early humoral reserve, but at this age it is not proof of the cause of zoster; impaired VZV-specific T-cell immunity is the central mechanistic concern.